|
|
Introduction
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
|
..
|
|
Cells are structurally and functionally
divided into a series of compartments among which the pathways of
metabolism are precisely allocated, creating a network of specialized
and complementary reaction vessels (see Protein trafficking).
The nucleus, cytosol, mitochondria, endoplasmic reticulum, Golgi,
plasma membrane, and lysosomes each carry out distinct biochemical
pathways — for example, DNA synthesis, glycolysis, ATP synthesis,
membrane biosynthesis, glycosylation of proteins, transport of solutes,
and degradation of macromolecules, respectively — utilizing distinct
sets of enzyme proteins. This view of the cell, established during the
1950s and 1960s, raised "the sorting problem," a defining issue for
cell biology in the decades that followed: How does each compartment
acquire and maintain its unique spectrum of proteins? The cell-free
reconstitution of transport between compartments was pivotal in
elucidating the molecular mechanisms involved.
|
|
..
|
|
Background
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
|
..
|
|
The sorting problem was ripe for attack
by the late 1970s because of key findings that allowed it to be posed
in reasonably precise terms. George Palade had discovered that protein
transport can occur between otherwise separate membrane-bound
compartments of the cell. Palade and colleagues showed that secreted
(and probably other) proteins follow a transport route from the
endoplasmic reticulum (ER) to the Golgi and then to the cell surface
and suggested that membrane-bound vesicles mediate transport. Günter
Blobel had just discovered that these proteins carry built-in signal
peptides that direct them into the ER even during their synthesis on
cytoplasmic ribosomes and proposed that proteins quite generally have
signal sequences that specify their location in the cell, now a basic
principle. And, Michael Brown and Joseph Goldstein (in the course of
elucidating the mechanism of cholesterol homeostasis; see The discovery of the LDL receptor:
Clues to receptor-mediated endocytosis)
had just provided the first clear demonstration that selective
transport between compartments is mediated by vesicles. They found that
transient "coated vesicles," budding from the plasma membrane, carry
out the endocytosis of plasma lipoproteins, allowing their cholesterol
to be released in lysosomes. These vesicles garner lipoproteins from
the medium by means of a receptor localized to the coated regions of
membrane involved in budding.
|
|
..
|
|
The sorting problem asks how transport
vesicles bud from one compartment and fuse with another one, carrying a
chosen set of proteins while leaving others behind. Figuring this out
was beyond the reach of microscopy and cell fractionation, which were
the main techniques then available to cell biologists but which could
reveal neither the underlying protein machinery nor its mechanism.
Clearly, new approaches would be needed to accomplish this. One avenue
was initiated by Randy Schekman (774), who found ways to
select transport mutants of yeast, which permitted protein machinery to
be found by molecular cloning of complementing genes when
transformation of yeast became possible.
|
|
..
|
|
I chose cell-free reconstitution because
it had been the central experimental approach of all biochemistry since
the discovery of alcoholic fermentation in yeast extracts by the
Buchner brothers at the end of the 19th century. Once
reconstituted, cell-free transport could be used as an assay to permit
the underlying enzyme proteins to be discovered and purified according
to their functional requirements. At the time of our experiment, the
mechanisms of ATP synthesis, DNA replication, RNA transcription,
protein synthesis, and even the genetic code, were all relatively
recent trophies of the reconstitution approach. However, reconstituting
intracellular transport seemed especially daunting because membrane
compartments are often in intimate proximity in the living cell, and it
was then common wisdom that if these spatial relationships were
destroyed by homogenization then transport could no longer take place.
This strong prejudice — deeply rooted in cell biology from its origin
as a branch of microscopic anatomy — no doubt accounted for the
skepticism with which our experiment reconstituting transport was
greeted for a number of years, until we began to isolate protein
machinery.
|
|
..
|
|
The goal of our experiment was to detect
transport of a protein between membrane-bound compartments in a
cell-free extract. We chose the integral membrane glycoprotein ("G"
protein) of vesicular stomatitis virus (VSV), then a favorite for
studying membrane biogenesis in animal cells in the days (late 1970s)
before it was possible to routinely express cloned genes. G protein is
the virus-encoded fusion protein needed for virions to enter and infect
cells. It forms the spikes that stud the surface of the virion and is
acquired as the virus exits the cell by budding at the plasma membrane.
VSV shuts off synthesis of proteins encoded by the host cell and
replaces them with its own gene products. G protein is the only protein
among them that enters the secretory pathway. The stepwise maturation
of G protein's Asn-linked oligosaccharide chains can be conveniently
monitored to delineate the progress of G protein within the ER and
Golgi because successive maturation steps occur in successive
compartments.
|
|
..
|
Figure 1
Processing of N-linked oligosaccharides in the
secretory pathway. N-linked complexes become resistant to cleavage by
Endoglycosidase H following addition of N-acetylglucosamine by GlcNAc
transferase I and subsequent release of mannose residues by Golgi
mannosidase II in the medial Golgi.
|
|
..
|
Figure 2
Time course of acquisition of Endo-H resistance by VSV G protein.
Cells were pulse-labeled with 35S-methionine for 5 minutes and homogenized.
Extracts were then incubated without 35S-methionine
for the times indicated. After 5 minutes pulse-labeling, the newly
synthesized G protein is Endo-H sensitive (compare first two lanes).
Between 5 and 10 minutes' incubation in vitro, G protein becomes
Endo-H resistant. N and NS are non-secreted VSV proteins. (Adapted from 1887.)
|
|
..
|
|
The pathway by which Asn-linked
oligosaccharide chains are matured by processing had then only recently
been uncovered by Stuart Kornfeld and others. As shown in Figure 1,
it entails the initial addition of a precursor oligosaccharide to the
protein in the ER, followed by the sequential removal of certain
glucose and mannose residues, and then the addition of the "terminal"
sugars N-Acetyl-Glucosamine (GlcNAc), galactose, and sialic
acid at successive locations within the Golgi stack. Phillips Robbins
had just worked out a neat shortcut for following saccharide processing
using SDS protein gels that exploits an unusual microbial
endoglycosidase (Endo H) that cleaves the precursor and immature
saccharide chains characteristic of the ER and early Golgi, but which
cannot cleave processed chains containing GlcNAc or other terminal
sugars added later in the Golgi (see Figure 1).
Since the saccharide chain (except for the single GlcNAc that is
directly linked to Asn) is removed, the overall molecular weight of the
glycoprotein is noticeably reduced and its band shifts on an SDS gel
(to the GS position; see Figure 2.
When only part of the population of G protein has entered and been
processed in the Golgi, two bands are observed: the parent band (GR,
resistant to EndoH) and the shifted band (GS,
sensitive to EndoH). Earlier methods for analysis of saccharide chains,
which involved multiple steps of fragmentation and chromatography that
required days, were prohibitive for the routine enzyme assay we
imagined that reconstitution of transport might become.
|
|
..
|
|
The experiment
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
|
..
|
|
The first attempts at reconstitution
began soon after I joined the Stanford biochemistry department in 1978
as an assistant professor. They were carried out by a fearless
postdoctoral fellow, Erik Fries, who I was fortunate to attract to the
project. Our initial goal was to obtain transport of VSV G proteinfrom
the ER to the Golgi in cell-free homogenates. Erik began by
radiolabeling VSV-infected hamster cells in tissue culture with 35S-methionine
for what we knew would be enough time (about 5 minutes) to allow newly
synthesized G protein to enter the ER while hardly entering the Golgi.
Then, we disrupted the cells, incubated the homogenate with ATP, and
determined whether any of the Endo H-sensitive G protein present at the
outset of the cell-free incubation in the ER had become Endo
H-resistant (which would indicate transport from the ER to the Golgi).
|
|
..
|
|
Little, if any, GR was produced. When we extended the labeling time, a small signal
(GR produced in the homogenate) did appear but it was quickly dwarfed by the
ever-increasing amount of GR
present in the homogenate at the outset of cell-free incubation due to
increasing amounts of G protein entering the Golgi in the cell. No
amount of tinkering with the cell-free conditions improved this
picture. Worse yet, we could not even be sure that our small signal
represented transport taking place in the homogenate.The extra GR produced in vitro
could merely have resulted from completion of processing on G protein
that had already reached the Golgi before cell disruption.
|
|
..
|
|
Facing this quandary led to the
breakthrough. I realized that a mutant hamster cell line (clone 15B)
defective in a specific glycosylation step in the Golgi could be
harnessed in a variation of the above experiment, both to eliminate the
background of Endo H-resistant G protein at the outset of the
incubation and to ensure that any glycosylation during the incubation
could only result from transport. That mutant, clone 15B, had been
isolated by Stuart Kornfeld on the basis of its resistance to an
ordinarily toxic plant lectin. It lacks the enzyme N-Acetyl-Glucosamine
Transferase I (NAGT-I; also known as GlcNAc transferase), normally
found in the central cisternae of the Golgi stack (see Figure 1).
As a result of their enzyme deficiency, 15B cells cannot process G
protein to Endo H-resistance although they transport the partially
processed G protein normally to the cell surface. G protein therefore
remains Endo H-sensitive in the ER, Golgi, and in the plasma membrane
of 15B cells. So, when homogenates of 35S-methionine-labeled,
VSV-infected 15B cells are incubated, the G protein in their membranes
will always remain Endo H-sensitive, even if it were to undergo further
transport.
|
|
..
|
|
The variation was simply to incubate two homogenates together
—
one (the "donor") produced from VSV-infected 15B mutant cells, and the other (the "acceptor")
produced from uninfected
wild-type cells. Now it is possible for Endo H-sensitive G protein
(originating in donor 15B membranes) to be processed by NAGT-I (present
in acceptor wild-type cell membranes) and thereby be made Endo
H-resistant. For example, if vesicles carrying the GS
protein were to bud off from donor ER membranes and fuse with the Golgi
membranes from the acceptor homogenate, then the transported GS
would be converted to GR. A bona fide
signal in this revised cell-free reaction explicitly requires that
proximity relationships in the cell are not essential for transport,
since transport would take place between organelles derived from
separate cells.
|
|
..
|
|
With this new design, we could indeed find in vivo
labeling conditions that allowed cell-free processing at about the same
rate and with about the same efficiency as transport in the cell, as
shown in Figure 2.
As in the cell, cell-free "transport-coupled glycosylation" is
ATP-dependent and occurs between closed membrane-bound compartments,
the latter shown by the resistance of the lumenally oriented spike
portion of G protein to external proteolytic attack (1887).
The first successful in vivo labeling conditions involved a short
"pulse"-label with 35S-methionine
followed by a 20-minute period of "chase" with unlabeled methionine in
the presence of a proton ionophore "uncoupler" that stops transport by
inhibiting ATP synthesis in mitochondria. That ATP (or other NTP) is
required for transport had been found in 1968 by James Jamieson and
George Palade, who used a similar protocol to block exit from the ER at
its "transitional elements," specialized regions where vesicles appear
to bud off from the Golgi. With this background, the simplest working
hypothesis was that we had reconstituted transport from transitional
elements of the ER (from 15B cells) to the Golgi (from wild-type
cells). However, we also recognized that the identity of the donor
compartment was not firmly established as the ER and could be a later
compartment (1887).
|
|
..
|
Figure 3
Assay for transport of VSV G protein to the medial
Golgi. 15B cells lack GlcNAc transferase I; thus, proteins in these
cells never acquire Endo-H resistance, although they are transported
through the secretory pathway. To assay for transport, the
Golgi-containing fraction from (radiolabeled) VSV-infected 15B cells is
incubated with the Golgi-containing fraction from uninfected wild-type
cells (plus ATP and cytosol). Acquisition of Endo-H resistance by G
protein is a measure of the extent of its transfer from donor
compartments to the medial Golgi.
|
|
..
|
|
Indeed, the latter proved to be the case. We subsequently found (1888)
that transport could be reconstituted without ATP depletion simply by extending
the in vivochase period by enough time (5-10 minutes) to allow the 35S-labeled
G protein to reach the 15B cell Golgi before homogenization. This
implied that the donor is the Golgi — not the ER or its transitional
elements. Since the acceptor is also a Golgi membrane, it followed that
transport between two Golgi stacks, one from the 15B cells and the
other from the wild-type cells, had been reconstituted (see Figure 3).
This was very surprising because it was then textbook knowledge that
the Golgi cisternae flow across the stack from its "immature" or
"forming" (now termed cis) face to its "mature" (now termed trans)
face. This view had been based on anatomical observations rather than
functional evidence. [Now, 20 years later, it is clear that transport
across the Golgi stack in animals results from a mix of cisternal flow
and vesicle transport, the latter being the dominant mechanism for most
proteins in most cells and the former important for transport of some
particles too large to be accommodated by vesicles (1896)].
The straightforward interpretation of our data was that transfer
between Golgi compartments can be mediated by vesicles, and that we had
reconstituted this process.
|
|
..
|
Figure 4
Left panel: VSV-infected 15B cells were pulse-labeled with 35S-methionine
for 5 minutes, then incubated in medium with unlabeled methionine for
0, 5, 10 or 20 minutes, and homogenized. Extracts were applied directly
to the gel. Note that in 15B cells the mature G protein has a slightly
lower apparent molecular weight than the immature G protein. L, N, NS
and M are non-secreted VSV proteins. Right panel: VSV-infected 15B
cells were pulse-labeled, and the radioactivity was chased as indicated
for the samples in the left panel. Cells were homogenized, and the
Golgi-containing fraction was incubated with the Golgi-containing
fraction from uninfected, unlabeled wild-type cells for 0, 20 or 40
minutes, then treated with Endo-H. Note that by 5 minutes chase in vivo
and 20 minutes incubation in vitro, Endo-H resistant G protein is detected.
(Adapted from 1888.)
|
|
..
|
|
As seen in Figure 4, Endo H-resistance is observed in samples
that had been labeled with a 5-minute pulse followed by a 5-minute chase in vivo
before homogenization and incubation with acceptor membranes. At this
time point, much of the labeled VSV G is known to be present in the
Golgi. However, no Endo H resistant G protein is produced in vitro
when cells were disrupted right after the 5-minute pulse (no chase); at
this time point, the labeled VSV G is still in the ER. With longer
times of chase G protein is progressively depleted from the donor Golgi
as it transfers to the plasma membrane before cell disruption, and
cell-free transport is correspondingly attenuated. Reexamination of our
first experiments confirmed that even though energy production was
poisoned, this did not occur instantly, and transport had continued
during the several minutes required for the cell to use all of its
existing ATP. This period was ample to permit much of the G protein to
enter the Golgi, thereby reconciling the two experiments. (It now turns
out that transport requires only about 10 μM ATP whereas cells normally
maintain about 1-3 mM ATP, so transport can continue until the cell has
used up most of its ATP.)
|
|
..
|
|
The strong dependence of the efficiency
of cell-free transport on the presence of VSV G protein in Golgi versus
other membranes convinced us that this was a bona fide reconstitution,
and not the result of nonspecific membrane fusion. More detailed analysis
(1881; 1882; 1884) soon confirmed this interpretation
and provided key improvements. Adding UDP-[3H]GlcNAc
(the donor of GlcNAc for glycosylation by NAGT-I) marks each
transported G protein with a fixed quantity of radioactivity as it
arrives in the acceptor Golgi. Transport is then simply measured by the
amount of [3H]-G protein produced. This improvement, made together with William Balch (1881),
made it possible to measure initial rates. This, in turn, allowed us to
harness the reconstitution as a rapid and routine quantitative assay to
guide the purification and discovery of required components.
|
|
..
|
Figure 5
Electron microscope autoradiograph showing that protein containing 3H-GlcNAc
is associated with Golgi stacks. The Golgi-containing fraction from
VSV-infected 15B cells was incubated with the Golgi-containing fraction
from wild-type cells that had taken up UDP- 3H-GlcNAc, and the mixture prepared for electron microscope autoradiography. (Adapted from 1884.)
|
|
..
|
Figure 6
The transport-coupled glycosylation assay was performed
with the donor Golgi fraction from VSV-infected 15B cells, and the
acceptor Golgi fraction from either rat liver or CHO cells that had
taken up UDP- 3H-GlcNAc. The mixtures were then prepared for
electron microscope autoradiography. Top panel: The number of Golgi
stacks with associated silver grains was counted and plotted as a
function of the Golgi stack size. Bottom panel: The number of stacks of
each size was counted from Golgi fractions that had not been incubated
in the glycosylation assay. The acceptor rat liver Golgi is
distinguished by its smaller size from donor 15B (and acceptor CHO
cell) Golgi. Since the same 15B Golgi fraction was used as the donor
with the different acceptor fractions, we concluded that the difference
in Golgi size is due to the acceptor fractions. These results showed
that G protein is transported from the mutant 15B Golgi to the rat
liver or CHO Golgi containing wild-type GlcNAc transferase I. (Adapted
from 1884.)
|
|
..
|
Figure 7
Vesicles bud from Golgi stacks. Left and right panels
show electron micrographs of representative donor Golgi fractions
incubated with cytosol and ATP for 15 minutes at 0°C (not primed) or at
37°C (primed), respectively. Red arrows indicate apparently budding
vesicles. (Adapted from 1881.)
|
|
..
|
|
With 3H to indicate the
transported G protein, we could now use autoradiography of electron
microscope sections to localize the acceptor site where the labeled
protein resides, as shown in Figure 5. This analysis, performed by William Braell (1884),
confirmed that the glycosylated G protein resides in morphologically
intact Golgi stacks derived from the acceptor homogenate. Thus, the
donor- and acceptor-derived Golgi stacks remain as two distinct and
unaltered populations, and the processed G protein resides exclusively
in the acceptor-derived Golgi population (Figure 6),
forcefully implying that G protein is transferred between them by
vesicles. We then showed by electron microscopy that 70-90 nm-diameter
vesicles containing G protein form at the donor Golgi stacks, as shown
in Figure 7 (1882).
Later work directly demonstrated that these vesicles are captured by
the acceptor stacks and thereby equilibrate between the two populations
(1895).
|
|
..
|
|
In retrospect, it is clear that all of
the stars were somehow aligned to make this work possible. I came from
outside the field of cell biology and therefore had no preconceived
notions of what could not be done. The existing background made it
clear that reconstitution of transport would be of critical importance.
Enough was known to formulate the experiment. And, not trivially, I was
fortunate to be in an ideal setting for the type of work involved. The
overall environment in the intimate and distinguished Stanford
Biochemistry department encouraged persistent risk-taking with the
long-range view in mind. In this supportive environment, I never was
forced to doubt that we would succeed — eventually. This climate was
the result of the dominant presence of Arthur Kornberg, unquestionably
the greatest practitioner (and preacher) of enzymology in the second
half of the 20th
century, and the main reason that I went to Stanford in the first
place. My postdoctoral work with Harvey Lodish at MIT taught me how to
work with cell-free reactions involving protein synthesis, and
introduced me to the VSV system. A collaboration with Phil Robbins at
MIT, while in Harvey's lab, made me aware of then-evolving details of
oligosaccharide processing, glycosylation mutant cell lines, and of
course Endo H. Phil generously donated this then-precious enzyme, and
Stuart Kornfeld did the same for 15B cells. Looking back now, I am
impressed with the important role an environment can play by
encouraging big thinking and supporting junior colleagues who have high
ambitions but low budgets. Also critical is the contribution that
senior scientists can make by providing key materials with "no strings
attached."
|
|
..
|
|
During the two decades since our
experiment was published, much progress in our understanding of the
Golgi apparatus has been made and it is now apparent that our original
reconstitution reproduced a rich array of transport processes that we
could not have envisioned at the time. The vesicles we saw budding from
Golgi stacks so many years ago (now termed coatomer or COPI-coated
vesicles) are actually a mixture of two closely related COPI-vesicles
that contain distinct cargo (779). The first population contains
the KDEL receptor (see The discovery of the KDEL retrieval signal)
but little VSV G protein; it carries retrograde traffic from the Golgi
back to the ER. The second kind of COPI vesicle is enriched in cargo
like VSV G protein that exit the Golgi at the trans face and
also contains small quantities of the resident proteins like
glycosyltransferases that are largely restricted to the Golgi stack.
Most likely, these vesicles percolate bidirectionally within the stack (1896),
although a current alternative view holds that they, like the first
population, may move primarily or even exclusively in the retrograde
direction. From either perspective, we had obtained a cell-free system
that faithfully reconstitutes the kinds of vesicle transport processes
that occur in the cell, and which would soon lead us to discover the
underlying principles universally used to bud and fuse vesicles.
|
|
..
|
|
The legacy
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
|
..
|
|
Virtually all of the transport pathways
linking cytoplasmic membrane compartments to each other and to the cell
surface were successfully reconstituted in cell-free extracts of animal
or yeast cells in the decade following the experiment (1902),
as have numerous other processes that (like vesicle transport) are
intimately connected to spatial asymmetry in the cell. This impressive
list includes the disassembly and reassembly of the nucleus (1894)
and the Golgi (1893) in the cell cycle, the polarized movement of organelles
along the cytoskeleton (1897), and the segregation of chromosomes at the mitotic
spindle in cell division (1889).
|
|
..
|
|
The cell-free system (and its partial
reactions) were utilized as functional assays with which to discover
the core protein machinery needed for vesicle budding, capture, and
fusion and with which to deduce the molecular mechanisms that are
involved (1892):
|
-
membrane fusion
—
the ATPase NSF (1883), SNAP proteins (782), and the SNARE complex; and the latter's role in mediating bilayer fusion as well as encoding its compartmental specificity (785).
-
vesicle budding
—
coatomers (1901) and ARF[GTP] (1898)
for Golgi transport vesicles; and the general GTP switch mechanism that
triggers budding by coat polymerization (GTP) followed by uncoating
(GDP) to permit fusion (1898).
-
vesicle capture/retention
—
p115 (1900), GM130 and giantin form flexible tethers (1899)
that extend from Golgi cisternae to form a matrix that retains COPI
vesicles on the stack while still allowing them lateral mobility. This
is a variant of the general mechanism that initially captures vesicles
for SNARE-dependent fusion at remote acceptor membranes (1892).
|
|
..
|
|
The past few years (1998-2000) have
witnessed a satisfying milestone in this body of research with the
reductionist demonstration (analogous to the classical proof of
structure through synthesis in chemistry) that coatomers, ARFs, and
SNAREs provide the crux mechanism of protein transport and sorting in
fully defined systems. Coatomers and an ARF[GTP] alone can bud vesicles
from pure lipid bilayers (1891); membrane proteins that bind
to the coatomers are packaged in the synthetic vesicles and they make
budding more efficient by coupling their packaging to coat
polymerization (1885). SNARE proteins alone efficiently fuse lipid bilayers (786)
with a pattern of specificity that closely reflects the organization of
transport pathways among the compartments in the cell (1183).
The core principles of budding and fusion are used over and over again
in one or another form throughout the cell to create a network that
connects the cell's compartments using groups of structurally or
functionally homologous proteins that are highly conserved in
evolution, so much so that they are frequently interchangeable between
species.
|
|
..
|
|
The sorting problem posed by cell
biologists a quarter century ago — understanding the mechanism and
specificity of protein flow within the cell — has been solved in its
principal features. Yet much remains to be learned about how regulatory
networks harness the now-familiar engine of core transport machinery to
flexibly adjust the pace and direction of membrane flow according to
the needs of the cell and tissue to permit an integrated response.
Looking ahead, we can expect existing genetic and biochemical
approaches combined with new imaging methods to reveal the versatile
means by which the principles of vesicle transport are employed in the
service of the physiology of the cell, the organ, and the organism in
health and in disease.
|
|
..
|
|
The author
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
James E. Rothman is Vice Chairman of the Sloan-Kettering Institute of
Memorial Sloan-Kettering Cancer Center and founding Chairman of its
Cellular Biochemistry and Biophysics Program. Prior to his current
appointment, Rothman was the E.R. Squib Professor of Molecular Biology
at Princeton University (1988-91) and Professor of Biochemistry at
Stanford University School of Medicine (1978-88). He received his B.A.
from Yale University in physics (1971), studied medicine at Harvard
Medical School (1971-73), received his Ph.D. in biochemistry from
Harvard (1976), and was a postdoctoral fellow at MIT (1976-78). Among
other honors, Rothman has received Canada's Gairdner Foundation
International Award (1996), Saudi Arabia's King Faisal International
Prize (1996), the National Academy of Sciences' Lounsbery Award, The
Netherlands' Heineken Prize (2000), and Germany's Otto-Warburg Medal
(2001). He is a Member of the U.S. National Academy of Sciences (1993)
and its Institute of Medicine (1995). His current work centers on the
biophysical mechanism and regulation of membrane fusion, and the design
of engineered fluorescent indicator proteins for monitoring the
activity of signaling and transport pathways in cells and tissues,
including those of the nervous system.
|
|
..
|
James E. Rothman
Cellular Biochemistry and Biophysics Program
Rockefeller Research Laboratory 517
Memorial Sloan-Kettering Cancer Center
1275 York Avenue, Box 251
New York, NY 10021
Phone: 212 639 8598
Fax: 212 717 3604
E-mail: j-rothman@ski.mskcc.org
|
|
..
|
|
Last Revised on October 12, 2004
|
|
..
|
-
1892 Mellman, I. and Warren, G.
(2000).
The road taken: past and future foundations of membrane traffic.
Cell 100, 99-112.
PubMed Journal
-
1896 Pelham, H. R. and Rothman, J. E.
(2000).
The debate about transport in the Golgi--two sides of the same coin?
Cell 102, 713-719.
PubMed Journal
-
1902 Cook, N. R. and Davidson, H. W.
(2001).
in vitro assays of vesicular transport.
Traffic 2, 19-25.
PubMed Journal
|
-
774 Novick, P., Field, C., and Schekman, R.
(1980).
Identification of 23 complementation groups required for posttranslational events in the yeast secretory pathway.
Cell 21, 205-215.
PubMed Journal
-
779 Orci, L., Stamnes, M., Ravazzola, M., Amherdt, M., Perrelet, A., Sollner, T.H., and Rothman, J.E.
(1997).
Bidirectional transport by distinct populations of COP-I-coated vesicles.
Cell 90, 335-349.
PubMed Journal
-
782 Clary, D. O., Griff, I. C., and Rothman, J. E.
(1990).
SNAPs, a family of NSF attachment proteins involved in intracellular membrane fusion in animals and yeast.
Cell 61, 709-21.
PubMed Journal
-
785 Söllner, T., Whiteheart, S. W., Brunner, M., Erdjument-Bromage, H., Geromanos, S., Tempst, P., and Rothman, J. E.
(1993).
SNAP receptors implicated in vesicle targeting and fusion.
Nature 362, 318-324.
PubMed Journal
-
786 Weber, T., Zemelman, B., McNew, J., Westermann, B., Gmachl, M., Parlati, F., Sollner, T.H., Rothman, J.E.
(1998).
SNAREpins: minimal machinery for membrane fusion.
Cell 92, 759-772.
PubMed Journal
-
1183 McNew, J. A., Parlati, F., Fukuda, R., Johnston, R. J., Paz, K., Paumet, F., Sollner, T. H., and Rothman, J. E.
(2000).
Compartmental specificity of cellular membrane fusion encoded in SNARE proteins.
Nature 407, 153-159.
PubMed Journal
-
1881 Balch, W. E., Dunphy, W. G., Braell, W. A.,
and Rothman, J. E. (1984). Reconstitution of the transport of
protein between successive compartments of the Golgi measured by the
coupled incorporation of N-acetylglucosamine. Cell 39,
405-416. PubMed Journal
-
1882 Balch, W. E., Glick, B. S., and Rothman, J. E.
(1984).
Sequential intermediates in the pathway of intercompartmental transport in a cell-free system.
Cell 39, 525-536.
PubMed Journal
-
1883 Block, M. R., Glick, B. S., Wilcox, C. A., Wieland, F. T., and Rothman, J. E.
(1988).
Purification of an N-ethylmaleimide-sensitive protein catalyzing vesicular transport.
Proc. Natl. Acad. Sci. USA 85, 7852-7856.
PubMed
-
1884 Braell, W. A., Balch, W. E., Dobbertin, D.
C., and Rothman, J. E. (1984). The glycoprotein that is
transported between successive compartments of the Golgi in a cell-free
system resides in stacks of cisternae. Cell 39, 511-524.
PubMed Journal
-
1885 Bremser, M., Nickel, W., Schweikert, M.,
Ravazzola, M., Amherdt, M., Hughes, C. A., Sollner, T. H., Rothman, J.
E., and Wieland, F. T. (1999). Coupling of coat assembly and
vesicle budding to packaging of putative cargo receptors.
Cell 96, 495-506. PubMed Journal
-
1887 Fries, E. and Rothman, J. E.
(1980).
Transport of vesicular stomatitis virus glycoprotein in a cell-free extract.
Proc. Natl. Acad. Sci. USA 77, 3870-3874.
PubMed
-
1888 Fries, E. and Rothman, J. E.
(1981).
Transient activity of Golgi-like membranes as donors of vesicular stomatitis viral glycoprotein in vitro.
J. Cell Biol. 90, 697-704.
PubMed
-
1889 Koshland, D. E., Mitchison, T. J., and Kirschner, M. W.
(1988).
Polewards chromosome movement driven by microtubule depolymerization in vitro.
Nature 331, 499-504.
PubMed Journal
-
1891 Matsuoka, K., Orci, L., Amherdt, M., Bednarek, S. Y., Hamamoto, S., Schekman, R., and Yeung, T.
(1998).
COPII-coated vesicle formation reconstituted with purified coat proteins and chemically defined liposomes.
Cell 93, 263-275.
PubMed Journal
-
1893 Misteli, T. and Warren, G.
(1994).
COP-coated vesicles are involved in the mitotic fragmentation of Golgi stacks in a cell-free system.
J. Cell Biol. 125, 269-282.
PubMed
-
1894 Newport, J.
(1987).
Nuclear reconstitution in vitro: stages of assembly around protein-free DNA.
Cell 48, 205-217.
PubMed Journal
-
1895 Orci, L., Malhotra, V., Amherdt, M.,
Serafini, T., and Rothman, J. E. (1989). Dissection of a single
round of vesicular transport: sequential intermediates for
intercisternal movement in the Golgi stack. Cell 56,
357-368. PubMed Journal
-
1897 Schnapp, B. J., Vale, R. D., Sheetz, M. P., and Reese, T. S.
(1985).
Single microtubules from squid axoplasm support bidirectional movement of organelles.
Cell 40, 455-462.
PubMed Journal
-
1898 Serafini, T., Orci, L., Amherdt, M.,
Brunner, M., Kahn, R. A., and Rothman, J. E. (1991).
ADP-ribosylation factor is a subunit of the coat of Golgi-derived
COP-coated vesicles: a novel role for a GTP-binding protein.
Cell 67, 239-253. PubMed Journal
-
1899 Sonnichsen, B., Lowe, M., Levine, T., Jamsa, E., Dirac-Svejstrup, B., and Warren, G.
(1998).
A role for giantin in docking COPI vesicles to Golgi membranes.
J. Cell Biol. 140, 1013-1021.
PubMed Journal
-
1900 Waters, M. G., Clary, D. O., and Rothman, J. E.
(1992).
A novel 115-kD peripheral membrane protein is required for intercisternal transport in the Golgi stack.
J. Cell Biol. 118, 1015-1026.
PubMed
-
1901 Waters, M. G., Serafini, T., and Rothman, J. E.
(1991).
'Coatomer': a cytosolic protein complex containing subunits of non-clathrin-coated Golgi transport vesicles.
Nature 349, 248-251.
PubMed Journal
|
|
..
|
|
©Jones and Bartlett Publishers (2007)
|
|